Healthcare - Biotechnology - NASDAQ - US
$ 0.051
-15 %
$ 99.5 M
Market Cap
None
P/E
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.[ Read More ]
The intrinsic value of one QSIAW stock under the base case scenario is HIDDEN Compared to the current market price of 0.051 USD, Quantum-Si incorporated is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart QSIAW
FINANCIALS
1.08 M
REVENUE
-111 M
OPERATING INCOME
-96 M
NET INCOME
-94 M
OPERATING CASH FLOW
143 M
INVESTING CASH FLOW
149 K
FINANCING CASH FLOW
787 K
REVENUE
-28.1 M
OPERATING INCOME
-25.3 M
NET INCOME
-23.2 M
OPERATING CASH FLOW
5.87 M
INVESTING CASH FLOW
2 K
FINANCING CASH FLOW
Balance Sheet Decomposition
Quantum-Si incorporated
| Current Assets | 266 M |
| Cash & Short-Term Investments | 258 M |
| Receivables | 368 K |
| Other Current Assets | 8.21 M |
| Non-Current Assets | 31.9 M |
| Long-Term Investments | 0 |
| PP&E | 30.7 M |
| Other Non-Current Assets | 1.23 M |
| Current Liabilities | 11.6 M |
| Accounts Payable | 1.77 M |
| Short-Term Debt | 3.13 M |
| Other Current Liabilities | 6.71 M |
| Non-Current Liabilities | 15 M |
| Long-Term Debt | 13.7 M |
| Other Non-Current Liabilities | 1.28 M |
EFFICIENCY
Earnings Waterfall
Quantum-Si incorporated
| Revenue | 1.08 M |
| Cost Of Revenue | 594 K |
| Gross Profit | 488 K |
| Operating Expenses | 112 M |
| Operating Income | -111 M |
| Other Expenses | -15.2 M |
| Net Income | -96 M |
RATIOS
45.10%
GROSS MARGIN
-10274.58%
OPERATING MARGIN
-8868.76%
NET MARGIN
-35.33%
ROE
-32.17%
ROA
-40.69%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Quantum-Si incorporated
| Net Income | -96 M |
| Depreciation & Amortization | 4.16 M |
| Capital Expenditures | -5.27 M |
| Stock-Based Compensation | 8.52 M |
| Change in Working Capital | -6.58 M |
| Others | -6.06 M |
| Free Cash Flow | -99.3 M |
Wall Street Analysts Price Targets
Quantum-Si incorporated
QSIAW has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
2.30%
DIVIDEND YIELD
0 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Quantum-Si incorporated
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
1 year ago
Mar 15, 2023
|
Bought 35.4 K USD
|
LaPointe Christian
General Counsel & Corp. Secr. |
+ 20000
|
1.77 USD |
|
1 year ago
Dec 15, 2022
|
Sell 191 K USD
|
RAKIN KEVIN
Director |
- 89000
|
2.1487 USD |
|
2 years ago
Jan 10, 2022
|
Sell 1.01 M USD
|
Stark John VIII
Chief Executive Officer |
- 172167
|
5.8561 USD |
|
2 years ago
Jan 11, 2022
|
Sell 48.4 K USD
|
Stark John VIII
Chief Executive Officer |
- 7702
|
6.2841 USD |
|
2 years ago
Jan 10, 2022
|
Sell 70.9 K USD
|
LaPointe Christian
General Counsel & Corp. Secr. |
- 12111
|
5.8561 USD |
|
2 years ago
Jan 11, 2022
|
Sell 3.41 K USD
|
LaPointe Christian
General Counsel & Corp. Secr. |
- 542
|
6.2841 USD |
7. News
8. Profile Summary
Quantum-Si incorporated QSIAW
COUNTRY
US
INDUSTRY
Biotechnology
MARKET CAP
$ 99.5 M
Dividend Yield
2.30%
Description
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.
Contact
29 Business Park Drive, Branford, 06405
https://www.quantum-si.com
IPO Date
None
Employees
159
Officers
Mr. Todd C. Bennett
Chief Commercial Officer
Mr. Jeffry R. Keyes CPA
Chief Financial Officer & Treasurer
Mr. Jeffrey Alan Hawkins
President, Chief Executive Officer & Director
Dr. Jonathan M. Rothberg Ph.D.
Founder & Executive Director
Mr. Todd Rearick
Chief Technology Officer
Mr. Juan Esteban Avendano
Vice President of Investor Relations
Mr. Alex A. Hutcheson
Senior Vice President of Sales & Service
Ms. Katherine Atkinson
Senior Vice President of Demand Generation & Corporate Brand
Mr. Johan Denecke
Senior Vice President of Operations
Mr. John S. Vieceli
Chief Product Officer